Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.

Jain S, Roy S, Amin M, Acquafondata M, Yin M, Laframboise W, Bastacky S, Pantanowitz L, Dhir R, Parwani A.

Am J Surg Pathol. 2013 Dec;37(12):1824-30. doi: 10.1097/PAS.0000000000000108.

2.

LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.

Zheng G, Chaux A, Sharma R, Netto G, Caturegli P.

Exp Mol Pathol. 2013 Feb;94(1):29-32. doi: 10.1016/j.yexmp.2012.05.008. Epub 2012 Jun 12.

3.

[Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].

Zhang W, Wang K, Yu W, Liu Y, Chu J, Jiang Y, Li Y.

Zhonghua Bing Li Xue Za Zhi. 2015 Nov;44(11):767-71. Chinese.

PMID:
26888385
4.

Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.

Geramizadeh B, Ravanshad M, Rahsaz M.

Indian J Pathol Microbiol. 2008 Apr-Jun;51(2):167-71.

5.

HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.

Conner JR, Hirsch MS, Jo VY.

Cancer Cytopathol. 2015 May;123(5):298-305. doi: 10.1002/cncy.21530. Epub 2015 Mar 4.

6.

DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.

Zhao W, Tian B, Wu C, Peng Y, Wang H, Gu WL, Gao FH.

Pathol Res Pract. 2015 Apr;211(4):303-7. doi: 10.1016/j.prp.2014.12.014. Epub 2014 Dec 30.

PMID:
25596994
7.

Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma.

Kuroda N, Kanomata N, Yamaguchi T, Imamura Y, Ohe C, Sakaida N, Hes O, Michal M, Shuin T, Lee GH.

Med Mol Morphol. 2011 Jun;44(2):111-5. doi: 10.1007/s00795-009-0461-z. Epub 2011 Jun 30.

PMID:
21717314
8.

Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.

Osunkoya AO, Cohen C, Lawson D, Picken MM, Amin MB, Young AN.

Hum Pathol. 2009 Feb;40(2):206-10. doi: 10.1016/j.humpath.2008.07.002. Epub 2008 Sep 16.

PMID:
18799195
9.

Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.

Foix MP, Dunatov A, Martinek P, Mundó EC, Suster S, Sperga M, Lopez JI, Ulamec M, Bulimbasic S, Montiel DP, Alaghehbandan R, Peckova K, Pivovarcikova K, Ondrej D, Rotterova P, Skenderi F, Prochazkova K, Dusek M, Hora M, Michal M, Hes O.

Virchows Arch. 2016 Dec;469(6):669-678. Epub 2016 Sep 15.

PMID:
27631338
10.

Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.

Tan MH, Wong CF, Tan HL, Yang XJ, Ditlev J, Matsuda D, Khoo SK, Sugimura J, Fujioka T, Furge KA, Kort E, Giraud S, Ferlicot S, Vielh P, Amsellem-Ouazana D, Debré B, Flam T, Thiounn N, Zerbib M, Benoît G, Droupy S, Molinié V, Vieillefond A, Tan PH, Richard S, Teh BT.

BMC Cancer. 2010 May 12;10:196. doi: 10.1186/1471-2407-10-196.

11.

Utility of immunohistochemical analysis of KAI1, epithelial-specific antigen, and epithelial-related antigen for distinction of chromophobe renal cell carcinoma, an eosinophilic variant from renal oncocytoma.

Ohe C, Kuroda N, Takasu K, Senzaki H, Shikata N, Yamaguchi T, Miyasaka C, Nakano Y, Sakaida N, Uemura Y.

Med Mol Morphol. 2012 Jun;45(2):98-104. doi: 10.1007/s00795-011-0546-3. Epub 2012 Jun 21.

PMID:
22718295
12.

Immunohistochemical analysis of cytochrome C oxidase facilitates differentiation between oncocytoma and chromophobe renal cell carcinoma.

Adam AC, Scriba A, Ortmann M, Huss S, Kahl P, Steiner S, Störkel S, Büttner R.

Appl Immunohistochem Mol Morphol. 2015 Jan;23(1):54-9. doi: 10.1097/PAI.0000000000000036.

PMID:
25265428
13.

Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.

Bing Z, Lal P, Lu S, Ziober A, Tomaszewski JE.

Ann Diagn Pathol. 2013 Feb;17(1):58-62. doi: 10.1016/j.anndiagpath.2012.07.002. Epub 2012 Aug 14.

PMID:
22898056
14.
15.

p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma.

McHugh JB, Hoschar AP, Dvorakova M, Parwani AV, Barnes EL, Seethala RR.

Head Neck Pathol. 2007 Dec;1(2):123-31. doi: 10.1007/s12105-007-0031-4. Epub 2007 Oct 26.

17.

Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.

Kruck S, Hennenlotter J, Vogel U, Schilling D, Gakis G, Hevler J, Kuehs U, Stenzl A, Schwentner C.

BJU Int. 2012 Feb;109(4):634-8. doi: 10.1111/j.1464-410X.2011.10392.x. Epub 2011 Jun 28.

18.

Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors.

Tickoo SK, Amin MB, Linden MD, Lee MW, Zarbo RJ.

Am J Surg Pathol. 1997 Aug;21(8):922-30.

PMID:
9255255
19.

Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study.

Huang W, Kanehira K, Drew S, Pier T.

Appl Immunohistochem Mol Morphol. 2009 Jan;17(1):12-7. doi: 10.1097/PAI.0b013e318173e79d.

PMID:
18769342
20.

Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.

Kuehn A, Paner GP, Skinnider BF, Cohen C, Datta MW, Young AN, Srigley JR, Amin MB.

Am J Surg Pathol. 2007 Oct;31(10):1528-33.

PMID:
17895753

Supplemental Content

Support Center